Semaglutide Plus Reduced Basal Insulin: What the SUSTAIN OPTIMIZE Trial Found 24th September 202616th August 2026 by Living Diabetes Editorial A 40-week randomized trial found that semaglutide added to reduced insulin glargine improved HbA1c and weight compared with titrated insulin alone, but gastrointestinal side effects were more common.
Human vs Analogue Insulin in Young People With Type 1 Diabetes: What the HumAn-1 Trial Found 24th September 20267th July 2026 by Living Diabetes Editorial The HumAn-1 trial found no clear CGM advantage for glargine over usual-care human insulin regimens at 6 months in young people with type 1 diabetes.
